AMC
TEVA icon

Asset Management Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Asset Management Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,644
Closed -$131K – 161
2020
Q2 		$131K Sell
10,644
-5,000
-32% -$56.5K 0.08% 122
2020
Q1 		$140K Buy
15,644
+250
+2% +$2.56K 0.13% 119
2019
Q4 		$151K Buy
+15,394
New +$137K 0.11% 151

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Asset Management Corp's TEVA Position: Q3 2020 in Review

Asset Management Corp sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 10,644 shares — an estimated $131K sold.

Asset Management Corp first reported a position in TEVA in Q4 2019 and held it in 3 quarters. The position peaked at $151K in Q4 2019. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Asset Management Corp reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Asset Management Corp sold 10,644 Teva Pharmaceuticals shares in Q3 2020, an estimated $131K.
  • Asset Management Corp first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Asset Management Corp's Teva Pharmaceuticals position peaked at $151K in Q4 2019.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Asset Management Corp's 13F filing for Q3 2020, filed 26 Oct 2020.